This Program Will Discuss

Slides:

Advertisements

Similar presentations

Monotherapy Versus Combination Therapy

Advertisements

Antibiotics: Novel and Rediscovered Stephen Swanson, MD, DTM&H Pediatric Infectious Diseases, Travel Medicine Department of Pediatrics Hennepin County.

Choosing Antimicrobials in Special Situations. Additional considerations in making a final antibiotic selection Site of action – (Will the antibiotic.

Community-Acquired MRSA:

Outpatient management of skin and soft tissue infections, specifically for community-associated MRSA Patient presents with signs/ symptoms of skin infection:

C-1 Staphylococcus aureus Bacteremia and Endocarditis: A Bad Bug and A New Drug G. Ralph Corey M.D. Professor of Internal Medicine and Infectious Diseases.

1 One Year Post-Exclusivity Adverse Event Review: Ertapenem Pediatric Advisory Committee Meeting November 16, 2006 Alan M. Shapiro, MD, PhD, FAAP Medical.

Management of Neutropenic Fevers in cancer patients Jerry Yu.

Journal of the Pediatric Infectious Diseases Society Advance Access published June 2, 2014.

Center for Drug Evaluation and Research Anti-Infective Drug Advisory Committee March 6, New Drug Application NDA /S-008 Cubicin® (daptomycin.

PGY 李忠興黃心慧郭雅婷戴維辰葛宗昀指導醫師：鍾福財醫師 Introduction Hospital-acquire pneumonia(HAP) – Most frequent type of infection in ICU – Mortality: 15-57%

1 Review of Efficacy Data New Drug Application NDA /S-008 Cubicin® (daptomycin for injection) Alfred Sorbello, DO Medical Officer FDA, CDER Center.

Tigecycline use in serious nosocomial infections: a drug use evaluation Matteo Bassetti*, Laura Nicolini, Ernestina Repetto, Elda Righi, Valerio Del Bono,

1 Issues in Conduct of Catheter Related Infection (CRI) Studies Charles Knirsch, MD, MPH FDA Anti-infective Advisory Committee Meeting October 14, 2004.

Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.

MRSA Infections Treatment Recommendations

By: Wajidah Abdul-Khabir PGY-2

The most common cause of impetigo is Staphylococcus aureus

Clinical Microbiology and Infection

Upfront Combination Therapy vs Step-Up Approach for PAH:

Antimicrobial Therapy. David H

Copyright © 2015 by the American Osteopathic Association.

The Role of the Microbiology Laboratory in AMS programs

Folliculitis, shown in Fig

Copyright © 2008 American Medical Association. All rights reserved.

به نام خدا.

New ESMO Guidance on Tumor Sidedness in mCRC

Gram-positive infections: lessons learnt and novel solutions

A Paradigm Shift in PAH.

Alpha-1 Antitrypsin Deficiency in COPD

The HCV Revolution: Are You and Your Practice Ready?

Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus.

Clinical Microbiology and Infection

The challenges of multi-drug-resistance in hepatology

Treatment of Complicated Intra-abdominal Infections

Resistant Hypertension

Clinical Microbiology and Infection

SGLT2 Inhibitors in the Modern Era: Why and Where?

Advances in Cystic Fibrosis Views and Perspectives From Basel, Switzerland, 2016.

The State of Pneumococcal Disease Prevention

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus.

Examining the Latest Evidence in PAH

Advancing the Treatment of IBD With Biologics

Empirical antibiotic treatment algorithm for hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). Empirical antibiotic treatment algorithm.

Treating CD30-Expressing Cutaneous T-Cell Lymphoma

J.-P. Stahl Clinical Microbiology and Infection

Clindamycin vs TMP-SMX for Uncomplicated Skin Infections

Treatment of staphylococcal infections with cyclic lipopeptides

Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.

Randomized, Controlled Trial of Antibiotics in the Management of Community-Acquired Skin Abscesses in the Pediatric Patient Myto Duong, MD, MS, Stephen.

Understanding and Addressing the Needs of Patients With AD

Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.

Bacterial resistance—the clinical challenge

Controlling Elevated Blood Pressure

Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators

Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated.

A.W. Karchmer Clinical Microbiology and Infection

Selecting Treatment Approaches in Hemophilia

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.

AMD Therapy: Where Are We Now and Where Are We Going?

Infection services in the intensive care unit

Clinical Considerations in Evidence-based Management of GIST

VTE Treatment and Secondary Prevention VTE Treatment Trials Initial Dosing.

B.A. Cunha Clinical Microbiology and Infection

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

Test results: characterising the antimicrobial activity of daptomycin

Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis Bernard Grenier Clinical.

J. Segreti Clinical Microbiology and Infection

Presentation transcript:

Optimizing Gram-Positive Bacterial Infection therapy in the Pediatric setting

This Program Will Discuss

S aureus Infection and SSTIs: Background

Clindamycin and TMP-SMX

Vancomycin

Linezolid

Daptomycin

Daptomycin: Efficacy in S aureus, Bacteremia, and Endocarditis

Drug Resistance

Daptomycin: Efficacy in Children With Complicated SSTIs – Clinical Trial Data

Daptomycin: Efficacy in Children With Complicated SSTIs – EU-CORE Registry Data

Daptomycin: Next Steps

Treatment of MRSA in Children: IDSA Guidelines

Combination Antibiotic Therapy for Serious Infections

Key Clinical Points

Key Clinical Points (cont)

Future Directions

Abbreviations